Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 0.903 Q2 | 202 | 432 | 892 | 53007 | 3275 | 828 | 3.62 | 122.70 | 44.94 | |
2 | Current Molecular Pharmacology | journal | 0.629 Q3 | 49 | 28 | 98 | 2442 | 237 | 85 | 2.87 | 87.21 | 44.53 | |
3 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.603 Q3 | 52 | 29 | 94 | 2940 | 250 | 91 | 2.75 | 101.38 | 44.35 | |
4 | Current Genomics | journal | 0.766 Q3 | 77 | 60 | 165 | 3531 | 435 | 146 | 2.68 | 58.85 | 37.33 | |
5 | Mini-Reviews in Medicinal Chemistry | journal | 0.500 | 107 | 120 | 425 | 10067 | 1162 | 394 | 2.65 | 83.89 | 36.87 | |
6 | Current Drug Targets | journal | 0.741 Q2 | 119 | 139 | 552 | 15568 | 1470 | 500 | 2.63 | 112.00 | 40.24 | |
7 | Current Cancer Drug Targets | journal | 0.893 Q3 | 103 | 81 | 240 | 6341 | 652 | 219 | 2.62 | 78.28 | 42.96 | |
8 | Current Protein and Peptide Science | journal | 0.666 Q3 | 96 | 121 | 329 | 11284 | 727 | 291 | 2.31 | 93.26 | 39.55 | |
9 | Current Gene Therapy | journal | 0.782 Q2 | 80 | 44 | 128 | 2998 | 283 | 115 | 2.29 | 68.14 | 40.22 | |
10 | Current Diabetes Reviews | journal | 0.687 Q3 | 68 | 67 | 177 | 3411 | 403 | 164 | 2.04 | 50.91 | 42.98 | |
11 | Current Organic Synthesis | journal | 0.330 Q4 | 55 | 82 | 252 | 5517 | 475 | 242 | 2.02 | 67.28 | 40.15 | |
12 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.543 Q3 | 108 | 198 | 590 | 11794 | 1247 | 566 | 1.98 | 59.57 | 43.53 | |
13 | Current Nanoscience | journal | 0.246 Q3 | 52 | 72 | 245 | 4405 | 392 | 229 | 1.88 | 61.18 | 35.04 | |
14 | Current Bioinformatics | journal | 0.333 Q3 | 38 | 87 | 209 | 3858 | 279 | 195 | 1.63 | 44.34 | 35.80 | |
15 | Open Medicinal Chemistry Journal | journal | 0.220 Q4 | 23 | 6 | 31 | 245 | 49 | 29 | 1.59 | 40.83 | 38.24 | |
16 | Current Aging Science | journal | 0.404 Q4 | 42 | 14 | 100 | 788 | 138 | 92 | 1.46 | 56.29 | 39.53 | |
17 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.330 Q4 | 45 | 27 | 69 | 2335 | 104 | 65 | 1.42 | 86.48 | 40.31 | |
18 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.271 Q4 | 39 | 22 | 89 | 1452 | 110 | 80 | 1.36 | 66.00 | 30.38 | |
19 | Letters in Drug Design and Discovery | journal | 0.240 Q4 | 37 | 115 | 445 | 5038 | 468 | 436 | 1.15 | 43.81 | 42.42 | |
20 | Recent Patents on Biotechnology | journal | 0.245 Q3 | 42 | 27 | 75 | 1544 | 80 | 67 | 1.11 | 57.19 | 38.83 | |
21 | Infectious Disorders - Drug Targets | journal | 0.267 Q4 | 61 | 54 | 89 | 2210 | 95 | 82 | 1.10 | 40.93 | 48.73 | |
22 | Drug Metabolism Letters | journal | 0.233 Q4 | 31 | 14 | 76 | 675 | 78 | 67 | 1.03 | 48.21 | 40.00 | |
23 | Current Pharmaceutical Analysis | journal | 0.286 Q3 | 27 | 89 | 218 | 2773 | 185 | 212 | 0.87 | 31.16 | 47.28 | |
24 | Current Computer-Aided Drug Design | journal | 0.216 Q4 | 32 | 40 | 105 | 1649 | 86 | 90 | 0.80 | 41.23 | 31.82 | |
25 | Letters in Organic Chemistry | journal | 0.211 Q4 | 33 | 129 | 378 | 5070 | 283 | 365 | 0.79 | 39.30 | 36.73 | |
26 | Open Biotechnology Journal | journal | 0.199 Q3 | 18 | 20 | 77 | 1057 | 68 | 74 | 0.73 | 52.85 | 45.00 | |
27 | Current Proteomics | journal | 0.234 Q4 | 27 | 46 | 119 | 2449 | 106 | 112 | 0.69 | 53.24 | 44.34 | |
28 | Current Enzyme Inhibition | journal | 0.204 Q4 | 19 | 20 | 64 | 609 | 40 | 59 | 0.68 | 30.45 | 45.16 | |
29 | International Journal of Engineering and Technology(UAE) (discontinued) | journal | 0.110 Q4 | 37 | 1 | 5601 | 25 | 3766 | 5600 | 0.67 | 25.00 | 0.00 | |
30 | Current Chemical Biology | journal | 0.167 Q4 | 26 | 25 | 51 | 1253 | 43 | 48 | 0.62 | 50.12 | 44.74 | |
31 | Current Signal Transduction Therapy | journal | 0.142 Q4 | 22 | 22 | 52 | 721 | 21 | 47 | 0.45 | 32.77 | 22.22 | |
32 | Current Cancer Therapy Reviews | journal | 0.128 Q4 | 17 | 25 | 47 | 1482 | 11 | 38 | 0.35 | 59.28 | 46.43 | |
33 | Journal of Biology and Today's World (discontinued) | journal | 0.113 Q4 | 8 | 0 | 76 | 0 | 25 | 75 | 0.33 | 0.00 | 0.00 | |
34 | Current Pharmacogenomics and Personalized Medicine | journal | 0.116 Q4 | 20 | 0 | 52 | 0 | 15 | 45 | 0.32 | 0.00 | 0.00 | |
35 | Open Biomarkers Journal | journal | 0.125 Q4 | 7 | 9 | 6 | 370 | 1 | 6 | 0.17 | 41.11 | 47.92 | |
36 | Current Metabolomics | journal | 0.144 Q4 | 4 | 0 | 6 | 0 | 4 | 5 | 0.00 | 0.00 | 0.00 | |
37 | Frontiers in Natural Product Chemistry | book series | 3 | 2 | 0 | 161 | 0 | 0 | 0.00 | 80.50 | 87.50 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®